Nutrien Ltd.
Nutrien Ltd. (NTR) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Nutrien Ltd. (NTR), featuring income statements, balance sheets, and cash flow data.
Nutrien Ltd. (NTR) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Nutrien Ltd. NTR financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.10B | $4.94B | $5.35B | $10.15B |
| Cost of Revenue | $3.78B | $3.50B | $3.85B | $7.004B |
| Gross Profit | $1.32B | $1.58B | $1.50B | $3.15B |
| Gross Profit Ratio | $0.26 | $0.32 | $0.28 | $0.31 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $956.00M | $1.07B | $977.00M | $1.18B |
| Operating Expenses | $1.09B | $1.11B | $1.50B | $1.34B |
| Total Costs & Expenses | $4.87B | $4.29B | $4.56B | $8.58B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $179.00M | $189.50M | $184.00M | $162.00M |
| Depreciation & Amortization | $571.00M | $590.00M | $598.00M | $586.00M |
| EBITDA | $797.00M | $1.009B | $796.00M | $1.43B |
| EBITDA Ratio | $0.16 | $0.20 | $0.15 | $0.14 |
| Operating Income | $226.00M | $471.00M | $265.00M | -$30.17M |
| Operating Income Ratio | $0.04 | $0.10 | $0.05 | -$0.003 |
| Other Income/Expenses (Net) | -$179.00M | -$269.00M | -$253.00M | $712.17M |
| Income Before Tax | $47.00M | $202.00M | $12.00M | $682.00M |
| Income Before Tax Ratio | $0.009 | $0.04 | $0.002 | $0.07 |
| Income Tax Expense | $28.00M | $84.00M | -$13.00M | $290.00M |
| Net Income | $11.00M | $113.00M | $18.00M | $385.00M |
| Net Income Ratio | $0.002 | $0.02 | $0.003 | $0.04 |
| EPS | $0.02 | $0.23 | $0.04 | $0.78 |
| Diluted EPS | $0.02 | $0.23 | $0.04 | $0.78 |
| Weighted Avg Shares Outstanding | $489.40M | $492.84M | $494.74M | $494.65M |
| Weighted Avg Shares Outstanding (Diluted) | $489.54M | $492.93M | $494.86M | $494.92M |
The company's financials show resilient growth, with revenue advancing from $10.15B in Q2 2024 to $5.10B in Q1 2025. Gross profit remained healthy with margins at 26% in Q1 2025 compared to 31% in Q2 2024. Operating income hit $226.00M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $797.00M. Net income dropped to $11.00M, while earnings per share reached $0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan